- Home
- ZD vs BHC Comparison
ZD vs BHC Comparison
Compare ZD & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZD
- BHC
- Stock Information
- Founded
- ZD 1995
- BHC N/A
- Country
- ZD United States
- BHC Canada
- Employees
- ZD N/A
- BHC N/A
- Industry
- ZD Advertising
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ZD Consumer Discretionary
- BHC Health Care
- Exchange
- ZD Nasdaq
- BHC Nasdaq
- Market Cap
- ZD 1.4B
- BHC 1.7B
- IPO Year
- ZD 1999
- BHC N/A
- Fundamental
- Price
- ZD $32.44
- BHC $4.53
- Analyst Decision
- ZD Hold
- BHC Hold
- Analyst Count
- ZD 6
- BHC 5
- Target Price
- ZD $49.67
- BHC $7.20
- AVG Volume (30 Days)
- ZD 585.2K
- BHC 1.5M
- Earning Date
- ZD 05-08-2025
- BHC 04-30-2025
- Dividend Yield
- ZD N/A
- BHC N/A
- EPS Growth
- ZD 36.58
- BHC N/A
- EPS
- ZD 1.76
- BHC N/A
- Revenue
- ZD $1,415,839,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- ZD $7.37
- BHC $3.71
- Revenue Next Year
- ZD $3.52
- BHC $5.03
- P/E Ratio
- ZD $18.46
- BHC N/A
- Revenue Growth
- ZD 3.24
- BHC 8.53
- 52 Week Low
- ZD $29.15
- BHC $3.96
- 52 Week High
- ZD $60.62
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- ZD 49.81
- BHC 39.91
- Support Level
- ZD $31.38
- BHC $4.50
- Resistance Level
- ZD $32.40
- BHC $4.61
- Average True Range (ATR)
- ZD 1.13
- BHC 0.13
- MACD
- ZD 0.16
- BHC 0.03
- Stochastic Oscillator
- ZD 51.11
- BHC 21.30
About ZD Ziff Davis Inc.
Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.